NSEInvestor Presentation3 Aug 2026 · 3 Aug 2026, 06:23 pm

Investor Presentation

Krishna Institute of Medical Sciences Limited · KIMS

✦ AI SummaryResults

Krishna Institute of Medical Sciences Limited has informed the Exchange about Investor Presentation, enclosing unaudited financial results for the 1st quarter ended June 30, 2026.

Analysis Scores

Earnings Impact8/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Krishna Institute of Medical Sciences Limited has informed the Exchange about Investor Presentation

Attachments (1)

📄

KIMS_03082026182345_investorpresentationfinal.pdf

pdf

Download →
View document text
03rd August 2026 The General Manager, The Manager, Department of Corporate Services Listing Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No.C/1, 'G' Block, Mumbai - 400 001. Bandra - Kurla Complex, Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS ISIN: INE967H01025 Dear Sir, Sub: Investor Presentation Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith the Investor Presentation on unaudited (Standalone & Consolidated) financial results of the Company for the 01st quarter ended 30th June 2026. The said presentation is being uploaded on the website of the Company i.e., https://www.kimshospitals.com/investors/Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015/Analysts Calls schedule, PPT & Transcripts/PPT's. We request you to take this on record. Thanking you, Yours truly, For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary & Compliance Officer Enclosed: As above Krishna Institute of Medical Sciences Limited D.No.: 1-8-31/1, Minister Road, Secunderabad - 500 003, Telangana, India Phone: +91 40 4488 5000/4488 5184 | Fax: +91-40-27840980 | kimshospitals.com CIN: L55101TG1973PLC040558 Investor Presentation August 03, 2026 Private & Confidential Disclaimer This presentation has been prepared by Krishna Institute of Medical Sciences Limited (the “Company”) solely for informational purposes. It should not be construed as an offer, solicitation, or recommendation to purchase or subscribe for any securities of the Company or its affiliates. The information contained herein has been compiled from sources believed to be reliable; however, the Company makes no representation or warranty, express or implied, as to the accuracy, completeness, or correctness of such information. Recipients are advised not to place undue reliance on this presentation and are encouraged to conduct their own independent analysis and consult with professional advisors before making any investment or business decisions. This presentation may contain forward-looking statements that involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance, or achievements of the Company to differ materially from those expressed or implied. These statements reflect the current expectations and beliefs of the Company’s management as of the date hereof and are subject to change without notice. The Company undertakes no obligation to update or revise any forward-looking statements in light of new information or future events. Neither the Company nor any of its directors, officers, employees, affiliates, or advisors accepts any liability whatsoever for any loss, cost, or damage arising directly or indirectly from the use of this presentation or its contents. This presentation has not been approved and will not be reviewed or approved by any statutory or regulatory authority in India or by any stock exchange(s) in India. This material does not purport to be comprehensive or to contain all the information a potential investor may require. Any investment decision should be based on a thorough review of publicly available information and independent professional advice suited to the specific circumstances of each investor. By accessing or attending this presentation, you acknowledge that you understand and agree to the terms of this disclaimer. Any disputes arising from or relating to this presentation shall be governed by and construed in accordance with the laws of India, and the courts in Hyderabad, Telangana, India shall have exclusive jurisdiction. Private & Confidential Driven by a Vision Affordable Quality Care Best-in-Class Facilities VISION: S Patient Centric Systems & Processes To be the most preferred T healthcare services brand by providing affordable care and best P clinical outcomes to patients. Clinical Outcome Driven Excellence And to be the best place to work R O Latest Medical Technology for doctors and employees. Strong Academics & Research Oriented OUR MISSION: Most Preferred Provide affordable quality care to Healthcare our patients with patient-centric Enriching Atmosphere systems and processes. Provider EMPLOYEES Collaborative Culture Enable clinical outcome-driven Growth Driven Career Approach excellence by engaging modern medical technology. I Provide a strong impetus for E doctors to pursue academics and Transparent Governance medical research. S Strong Operational Performance Consistent Growth Private & Confidential Multi Specialty Care Brain Eyes Bones and Spine Radiology • Neurology • Ophthalmology • Orthopedics • Imaging • Neurosurgery • Arthroscopic Surgery • Interventional Radiology Gastro Intestinal Tract • Psychiatry • Spine Surgery • Medical Gastroenterology Lab Services • Neuro Rehabilitation • Ortho Rehabilitation • Surgical Gastroenterology • Pathology Heart • Hepatobiliary Pancreatic Surgery Skin • Microbiology • Cardiology • Liver Transplant • Dermatology • Biochemistry • Cardiac Surgery • Bariatric Surgery • Cosmetology • Molecular Biology • Vascular Surgery • Plastic and Reconstructive Surgery • Clinical Hematology Genito Urinary Tract • Heart Transplant • Nephrology Orthodontics Critical Care Services • Cardio Rehabilitation • Urology • Maxillo Facial Surgery • ICU Lung • Andrology • CTICU Anaesthesia • Pulmonology • Renal Transplant • SICU • OT Anaesthesia • Interventional Pulmonology • Gynecology • NICU • Day care Anaesthesia • Thoracic surgery • Urogynecology • PICU • Pain Medicine • Lung Transplant • IVF and ART • Neuro ICU General Specialities • Fetal Medicine • ECMO ICU • Internal Medicine • Obstetrics • Post Transplant ICU • General Surgery • Nose Oncology Hospital Infection Control • Diabetology & Endocrinology • Throat • Medical Surgical and Radiation • Clinical Infectious Diseases Pediatrics • Head and Neck Surgery • BMT and Hematology • Pediatrics & Pediatric Sub Specialities • Neonatology Private & Confidential Dr. Bhaskara Rao Bollineni - Visionary Behind KIMS Chairman & Managing Director A legend in CT Surgery, Dr. Bhaskara Rao Bollineni {MBBS, MS, DNB (CT Surgery)} is one of the very few Cardio-Thoracic Surgeons in the country, who performed over 30000 surgeries in his career spanning over more than 25 years. Well known in the medical fraternity for his passion towards his profession, Dr. Bhaskara Rao Bollineni started his entrepreneurial journey at “Mahavir Cardio Vascular Centre” in Hyderabad with 50 beds and performed heart surgeries at an unimaginable low cost of just Rs. 45,000 only. Dr. Bhaskara Rao Bollineni never turned away any patient from the hospital for want of money. The brand “Krishna Institute of Medical Sciences”, under Dr. Bhaskara Rao Bollineni aegis began its journey in 2004 with a 300 bed hospital on par with the then established hospitals of Hyderabad in professional excellence, the state of art technology and infrastructure facilities. Today KIMS is spread across Telangana, Andhra Pradesh, Maharashtra, Karnataka and Kerala. Dr. Bhaskara Rao Bollineni was instrumental in formulating Rajiv Gandhi Aarogyasri scheme, first time launched in Andhra Pradesh in 2007 for providing health care to the poorest of the poor. This prestigious scheme has won him accolades from all quarters of the country and the world. He was the chief architect of Aarogyashri scheme for both creating it and implementing it successfully. This well formulated scheme has become so popular that the other States in India have emulated it time and again. Private & Confidential Dr. Abhinay Bollineni Executive Director & CEO Dr. Abhinay Bollineni joined KIMS Hospitals in 2013 and spent the next couple of years in Hospital Operations before taking charge of Strategy & Marketing for the Group in 2015. He was appointed as [Showing first 8,000 characters — download PDF for full document]